Northstar Group’s Thermo Fisher Scientific TMO Stock Holding History

Northstar Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$282K	Hold	573	–	–	0.04%	136
2025 Q4	$332K	Hold	573	–	–	0.05%	127
2025 Q3	$278K	Sell	573 -95	-14%	-$44.2K	0.04%	132
2025 Q2	$271K	Hold	668	–	–	0.04%	130
2025 Q1	$332K	Buy	668 +65	+11%	+$35.2K	0.05%	119
2024 Q4	$314K	Hold	603	–	–	0.05%	115
2024 Q3	$373K	Hold	603	–	–	0.07%	109
2024 Q2	$333K	Hold	603	–	–	0.06%	114
2024 Q1	$350K	Hold	603	–	–	0.07%	111
2023 Q4	$320K	Hold	603	–	–	0.07%	111
2023 Q3	$305K	Hold	603	–	–	0.07%	115
2023 Q2	$315K	Buy	603 +21	+4%	+$11.3K	0.07%	114
2023 Q1	$335K	Hold	582	–	–	0.09%	108
2022 Q4	$321K	Hold	582	–	–	0.09%	108
2022 Q3	$295K	Hold	582	–	–	0.09%	110
2022 Q2	$316K	Hold	582	–	–	0.09%	111
2022 Q1	$344K	Hold	582	–	–	0.08%	118
2021 Q4	$388K	Sell	582 -38	-6%	-$23.7K	0.09%	108
2021 Q3	$355K	Buy	620 +38	+7%	+$20.9K	0.09%	116
2021 Q2	$293K	Hold	582	–	–	0.08%	126
2021 Q1	$266K	Buy	582 +56	+11%	+$26.7K	0.08%	128
2020 Q4	$245K	Hold	526	–	–	0.08%	124
2020 Q3	$232K	Buy	+526	New	+$217K	0.08%	122

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northstar Group's TMO Position: Q1 2026 in Review

Northstar Group held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 573 shares worth $282K. The position accounts for 0.04% of the portfolio, ranked #136.

Northstar Group first reported a position in TMO in Q3 2020 and has held it in 23 quarters since. The position peaked at $388K in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Northstar Group held 573 shares of Thermo Fisher Scientific worth $282K as of Q1 2026.
Northstar Group left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.04% of Northstar Group's portfolio in Q1 2026, its #136 holding.
Northstar Group first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 23 quarters since.
Northstar Group's Thermo Fisher Scientific position peaked at $388K in Q4 2021.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Northstar Group's 13F filing for Q1 2026, filed 28 Apr 2026.